Create my account

eye
eye

Log in to your account

Log in now or create an account to benefit from a fully personalized Unimy Masters experience

Cannot remember your password? Forgot password?

Forgot password?

If you have forgotten your password, we will send you an email to reset your password.

icon

King's School of Basic & Medical Biosciences

Stem Cell & Regenerative Therapies: From Bench to Market MSc
Location icon

London United Kingdom

Duration icon

12 months Duration

Tuition icon

£ 44,496 Tuition

Format icon

Full time Format

Application deadline icon

Jul 26, 2024 Application deadline

Other available programs from King's School of Basic & Medical Biosciences

The first course of its kind in the UK, the Stem Cell & Regenerative Therapies: From Bench to Market MSc combines biological and medical science with business, law and bioethics. Designed to develop expertise in the biological, commercial and regulatory aspects of cellular therapies and its applications in biomedicine, the course equips students to pursue a business-based career in cellular therapy or related disciplines.

Key benefits

  • You will have the opportunity to work alongside key opinion leaders in the field of business and medical research in cellular therapies.
  • You will learn about the complex landscape of manufacturing and commercialising cells for medical treatment from those who deliver them.
  • You will produce credible business plans for the application of cellular therapy in clinical settings, taking into consideration science, patient benefits, regulations and market laws.
  • You will learn to conduct investigations, analyse the results using various qualitative and quantitative methods and draw valid conclusions for commercialisation of cellular therapy.
  • Outstanding networking opportunities with leaders in the field (biotechnology/pharma, financial services, stem cell manufacturing, regulatory, public sectors and scientists).
  • Mentoring sessions by King's academics and external guests.

 

Course essentials

The complexity of issues relating to cell manufacturing, the underlying regulatory framework, reimbursement and viable business models all represent challenges that severely undermine the timing and the delivery of a sustainable healthcare model. Our programme will equip you with the knowledge that will enhance the understanding of these complex issues within an integrated and commercial context. This one-year advanced study course explores the biological, regulatory and business aspects of cellular therapy in the fields of biomedicine. The course also includes a dissertation related to business strategy development for cellular therapy. You will study modules totalling 180 credits throughout the year, with 45 credits coming from the 15,000 – 18,000 word dissertation. The majority of learning for this degree takes place at the King’s College London Guy’s campus. Some of the lectures are also delivered at the Demark Hill and Waterloo campuses; please note that locations are determined according to where each module is taught.

  • Language Test: TOEFL 92 (minimum), IELTS 6.5 (minimum)
  • Other: Medical degree (MBBS or equivalent) or a 2.1/first degree (or overseas equivalent) in relevant bioscience subject. Non-traditional qualifications will be considered on an individual basis.
Are you sure?

By clicking yes you agree that your contact details (e-mail, names) may be shared with the particular graduate school admission office.